Bio Innovation Leaders Summit 2027
10–11 February 2027 · Berlin Palace Hotel · Invited Audience Only
For decision makers from small biotech to large Pharma.
Leadership must keep pace to evolve and stay competitive.
AI-powered bioprocessing, agile modular capacity, viral safety & QC and downstream purification — four critical buying centers now shaping resilient biomanufacturing.
01 · the Circle. BILS 2027
Opening Key Note
The Future of Biologics Manufacturing and Supply
Jens H. Vogel, Ph.D.
SVP & Head of Global Biologics Operating Unit at MSD
1. Safety, filtration and downstream purity
Filtration, viral safety and downstream purification move from compliance overhead into commercial lever. In 2027 they decide which products reach market first. Capacity is built at the line where speed and safety stop being a trade-off. Audit-led release ends. Engineered release begins.
2. Intelligent biomanufacturing
AI, automation and cloud move from pilot into the operating core of biomanufacturing. In 2027 they become the daily control lever for yield, quality and release. Decisions move with live process data, not the last deviation report. The era of experimentation ends. Industrialisation begins.
3. Workforce and human systems
Operators, scientists and engineers move from task execution into system orchestration. In 2027 they become the difference between automation that scales and automation that stalls. Expertise is amplified by technology, not displaced by it. Headcount-led capacity ends. Human-AI orchestration begins.
4. Sustainable resilient biomanufacturing
Energy, water and supply concentration move from disclosure into facility design. In 2027 they sit on the same balance sheet as cost of goods. Networks are engineered for resilience and decarbonisation at planning stage. Retrofit sustainability ends. Designed-in resilience begins.
02 · THE GAP
Curated for senior biomanufacturing leaders
Why it Matters.
Biomanufacturing supply is now a geopolitical surface.
In 2027 the response is regional. Capital is moving into local fill-finish, regional substance networks and country-level resilience. Sustainability has shifted from disclosure to design.
Three conversations. One decision.
The question is no longer whether these shifts are coming but how to deploy them without breaking cost, compliance or supply.
Intelligent biomanufacturing turns the plant into a learning system.
In 2027 every batch sharpens the next, every site informs the network, every deviation becomes signal rather than incident.
Forgetting ends. Compounding begins.
03 · WHO IT'S CURATED FOR
Where biologics leaders define what scales next.
Human-centred Industry 5.0 systems. Sustainable, resilient biomanufacturing and supply built for 2027 and beyond.
The people making those decisions are in this room.
MANUFACTURING & OPERATIONS
An invite‑only deployment room for leaders from small to large Biopharma.
VP Manufacturing · COO · Production Site Director · Head of Operations Engineering
Quality & Regulatory
VP Quality · Head of QA · Chief Quality Officer · Safety · Bioprocess
It is a curated, invite‑only meeting in London for senior decision makers from biologics, cell and gene therapy who sign off the next wave of capacity, technology and partnership commitments.
MSAT & PROCESS DEVELOPMENT
Head of MSAT · VP Tech Ops · Process Development Lead
Over two days the focus stays on four pillars – AI‑enabled bioprocessing, agile capacity and networks, workforce and human systems and sustainable resilient operations – because that is where 2027 decisions are actually made.
DIGITAL, DATA & R&D
VPs Innovation · VP Digital · Head of Data Science Digital Transformation Lead · Heads of R&D · Automation · Infrastructure
For technology providers and CDMOs BILS is where current bioprocess and biomanufacturing trends turn into multi‑year deployment roadmaps.
For operators it is a chance to stress‑test strategies with peers who are facing the same pressures on performance, resilience and sustainability and need answers they can put into practice in their own plants.
Advisory Circle.
Advisory & Past Speakers
For the few: Leaders Panel Discussion.
Step into the circle. Subscribe.
Stay updated. Receive the agenda. Partner with us.
